drugset / Trial / NCT03336840

Effect of Metformin and Probiotics in Reproductive-aged Patients With Polycystic Ovary Syndrome

NCT03336840

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this clinical trial is to evaluate the safety and effectiveness on the clinical and biological parameters of reproductive-aged PCOS women after a 12-week metformin and/or probiotics administration.

Timeline

Start
2017-06-01
Primary completion
2019-03
Completion
2019-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 0.5 g Oral
Subject ProMetS Other / unclassified 4 g Oral